Mitchel Sayare's Net Worth

$16.8 Million

Estimate Recalculated Feb 12, 2024 04:52PM EST

Who is Mitchel Sayare?

Mitchel Sayare has an estimated net worth of $16.8 Million. This is based on reported shares across multiple companies, which include IMMUNOGEN INC, and Altimmune, Inc..

SEC CIK

Mitchel Sayare's CIK is 0001201196

Past Insider Trading and Trends

2016 was Mitchel Sayare's most active year for acquiring shares with 11 total transactions. Mitchel Sayare's most active month to acquire stocks was the month of October. 2007 was Mitchel Sayare's most active year for disposing of shares, totalling 58 transactions. Mitchel Sayare's most active month to dispose stocks was the month of October. 2009 saw Mitchel Sayare paying a total of $756,385.00 for 168,759 shares, this is the most they've acquired in one year. In 2009 Mitchel Sayare cashed out on 441,263 shares for a total of $2,870,485.26, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNOGEN INC (IMGN) Snapshot price: $29.595

Chairman the Board

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.54%
-10.00K
$13.25
-$132,500.00
383.14K
Scheduled
Jul 29
Form 4
-2.48%
-10.00K
$15.02
-$150,200.00
393.14K
Scheduled
Jul 15
Form 4
-2.42%
-10.00K
$11.70
-$117,000.00
403.14K
Scheduled
Jun 24
Form 4
-2.36%
-10.00K
$11.69
-$116,920.00
413.14K
Scheduled
Jun 10
Form 4
-2.31%
-10.00K
$12.24
-$122,401.00
423.14K
Scheduled
May 27
Form 4
-2.26%
-10.00K
$13.23
-$132,325.00
433.14K
Scheduled
May 13
Form 4
-4.32%
-20.00K
$13.28
-$265,540.00
443.14K
Scheduled
Apr 29
Form 4
-4.14%
-20.00K
$12.11
-$242,180.00
463.14K
Scheduled
Apr 15
Form 4
-4.92%
-25.00K
$8.91
-$222,875.00
483.14K
Scheduled
Mar 31
Form 4
-4.69%
-25.00K
$8.50
-$212,600.00
508.14K
Scheduled
Mar 18
Form 4
—
0
—
—
0
Nov 16 - Nov 17
Form 4
+1.67%
8.74K
$7.42
-$37,215.26
533.14K
Nov 19 - Nov 20
Form 4
—
0
—
—
0
Nov 11
Form 4
-27.61%
-200.00K
$7.50
-$1,500,500.00
524.4K
Nov 5 - Nov 6
Form 4
+12.25%
80K
$2.25
$180,000.00
733.29K
Jan 5
Form 4
—
0
—
—
0
Jun 11
Form 4
+12.16%
127.96K
$2.83
-$127,264.15
1.18M
Nov 29 - Nov 30
Form 4
—
0
$2.84
-$162,697.89
526.28K
Nov 27 - Nov 28
Form 4
+4.99%
25K
$1.31
$32,812.50
526.28K
Aug 10
Form 4
+11.08%
50K
$1.31
$65,625.00
501.28K
Jul 30
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 8
Form 4
+16.71%
64.63K
$2.50
$161,562.50
451.28K
Mar 21
Form 4/A
+18.50%
60.38K
$2.50
$150,937.50
386.65K
Jan 31
Form 4
+18.50%
60.38K
$2.50
$150,937.50
386.65K
Jan 31
Form 4
—
0
—
—
0
Jun 9
Form 4
+29.85%
75K
$1.94
$145,350.00
326.28K
Mar 30
Form 4
+0.40%
1K
$5.98
$5,980.00
251.28K
Mar 2
Form 4
—
0
—
—
0
Jun 17
Form 4
+13.62%
30K
$5.13
$153,750.00
250.28K
Jun 7
Form 4
—
0
—
—
0
No matching records found

Altimmune, Inc. (ALT) Snapshot price: $10.325

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 28
Form 4
—
0
—
—
0
Sep 29
Form 4
—
0
—
—
0
Sep 23
Form 4
+2,323.07%
25.27K
—
—
26.36K
Sep 24
Form 4
—
0
—
—
0
Sep 24
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Apr 5
Form 4
+18.51%
5.1K
$1.95
$9,962.85
32.65K
Dec 29
Form 4
—
0
—
—
0
Oct 13
Form 4
+5,410.00%
270.5K
$2.09
$564,844.54
275.5K
Nov 22
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Aug 2
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 22
Form 4
∞
5K
$2.17
$10,850.00
5K
Aug 18
Form 4
—
0
—
—
0
Jul 15 - Jul 17
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Apr 27
Form 3
—
0
—
—
0
No matching records found